Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected corruption, China's anti-graft watchdog said on Thursday.

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

Bi, 69, served as the chief of the China Food and Drug Administration from 2015 to 2018, when he introduced regulatory overhauls that spurred innovation in China’s pharmaceutical sector.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...

Review of foreign scientists from countries like China began even before three Chinese scientists in Michigan were caught ...

U.S. Food and Drug Administration Commissioner Marty Makary described Chinese illicit vapes as a direct "attack" on the nation's youth.

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

China's growing biotech prowess has become a real threat to the industry in the US in recent years. Moves by the Trump administration could weaken the US market further, according to several experts ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...